Gronwald, Jacek; Tung, Nadine; Foulkes, William D et al. (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118:2281-4 |
Colilla, Susan; Kantoff, Philip W; Neuhausen, Susan L et al. (2006) The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis 27:599-605 |
Rebbeck, Timothy R; Friebel, Tara; Lynch, Henry T et al. (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055-62 |
Grushko, Tatyana A; Dignam, James J; Das, Soma et al. (2004) MYC is amplified in BRCA1-associated breast cancers. Clin Cancer Res 10:499-507 |
Armstrong, Katrina; Weber, Barbara; FitzGerald, Genevieve et al. (2003) Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. Am J Med Genet A 120A:359-64 |
Armstrong, Katrina; Weiner, Janet; Weber, Barbara et al. (2003) Early adoption of BRCA1/2 testing: who and why. Genet Med 5:92-8 |
Rebbeck, Timothy R; Lynch, Henry T; Neuhausen, Susan L et al. (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-22 |
Grushko, Tatyana A; Blackwood, M Anne; Schumm, Phil L et al. (2002) Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res 62:1481-8 |
Shih, Helen A; Couch, Fergus J; Nathanson, Katherine L et al. (2002) BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 20:994-9 |
Armstrong, Katrina; Stopfer, Jill; Calzone, Kathleen et al. (2002) What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Genet Test 6:115-8 |
Showing the most recent 10 out of 45 publications